Ferraccioli, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 7.000
EU - Europa 6.835
AS - Asia 1.389
SA - Sud America 39
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 17
Totale 15.340
Nazione #
US - Stati Uniti d'America 6.957
DE - Germania 1.786
SE - Svezia 1.054
CN - Cina 955
IT - Italia 802
PL - Polonia 734
UA - Ucraina 665
FR - Francia 596
IE - Irlanda 457
GB - Regno Unito 223
BE - Belgio 183
FI - Finlandia 180
IN - India 164
TR - Turchia 91
HK - Hong Kong 44
IR - Iran 36
JP - Giappone 36
CA - Canada 34
RU - Federazione Russa 28
CI - Costa d'Avorio 21
CH - Svizzera 17
NL - Olanda 17
AU - Australia 15
CZ - Repubblica Ceca 14
CL - Cile 13
RO - Romania 13
VN - Vietnam 13
BR - Brasile 12
EU - Europa 12
ES - Italia 11
DK - Danimarca 9
A2 - ???statistics.table.value.countryCode.A2??? 8
ZA - Sudafrica 8
NO - Norvegia 7
GR - Grecia 6
LK - Sri Lanka 6
SA - Arabia Saudita 6
AR - Argentina 5
BG - Bulgaria 5
ID - Indonesia 5
IL - Israele 5
MX - Messico 5
SG - Singapore 5
AT - Austria 4
CO - Colombia 4
EC - Ecuador 4
LV - Lettonia 4
TW - Taiwan 4
BD - Bangladesh 3
EE - Estonia 3
EG - Egitto 3
HU - Ungheria 3
IQ - Iraq 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
SI - Slovenia 3
A1 - Anonimo 2
KR - Corea 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SC - Seychelles 2
TH - Thailandia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 15.340
Città #
Chandler 1.287
Warsaw 602
Ashburn 490
Dublin 440
Ann Arbor 390
Jacksonville 388
Dearborn 371
San Mateo 318
Wilmington 287
Fairfield 273
Nanjing 249
Woodbridge 238
Cattolica 178
Houston 178
Brussels 176
Seattle 167
Boston 150
Lawrence 140
New York 131
Kraków 121
Milan 114
Beijing 105
Redwood City 92
Bremen 91
Marseille 85
Cambridge 83
Izmir 81
Nürnberg 81
Nanchang 76
Munich 68
Princeton 68
Rome 62
Kunming 60
Norwalk 57
Boardman 55
Lancaster 53
Pune 52
Mountain View 50
Hebei 46
Hong Kong 44
Shenyang 43
Guangzhou 39
Chicago 37
University Park 37
Hangzhou 36
Redmond 35
Tianjin 35
Falls Church 31
Helsinki 29
Hefei 27
Jiaxing 27
Changsha 25
London 24
Detroit 23
Fremont 23
Boydton 22
Jinan 22
Shanghai 22
Zhengzhou 22
Abidjan 21
Leawood 21
Andover 20
Augusta 19
Toronto 14
Fuzhou 13
San Diego 13
Simi Valley 13
Washington 12
Dong Ket 11
Kish 11
Ningbo 11
Tokyo 11
Ardabil 10
Santa Maria 10
Chengdu 9
Costa Mesa 9
Florence 9
Haikou 9
Paris 9
Phoenix 9
Changchun 8
Clearwater 8
Lanzhou 8
Torino 8
Brno 7
Edinburgh 7
Xian 7
Zurich 7
Dallas 6
Herenthout 6
Melbourne 6
Monmouth Junction 6
Moscow 6
Rozzano 6
Wenzhou 6
Wuhan 6
Amsterdam 5
Bari 5
Bern 5
Bologna 5
Totale 8.948
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 372
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. 329
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 317
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 293
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 265
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 254
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 230
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 205
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 189
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 174
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment 169
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 166
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 159
Septic sacroiliitis: an uncommon septic arthritis 146
Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide 144
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 135
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 134
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 133
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 131
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 129
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 128
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 127
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 124
Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in Early Rheumatoid Arthritis. 121
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein 121
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 121
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 120
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 119
Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis 118
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 117
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 116
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 114
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 114
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 111
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 109
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 108
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 108
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 108
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 107
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 106
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 103
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 102
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 102
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 99
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 98
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 97
Preliminary classification criteria for the cryoglobulinaemic vasculitis 97
New therapeutic effects of cilostazol in patients with ischemic disorders. 96
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 94
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 93
The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. 92
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 89
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 85
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 85
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 83
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 82
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 82
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 81
Artrite reumatoide. Terapia 81
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 80
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 80
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 79
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 79
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 79
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 79
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 78
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 77
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 76
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 76
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 76
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 75
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 74
Polimialgia reumatica ed arterite temporale di Horton 74
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 72
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 71
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 70
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: A post hoc analysis of a phase III trial 70
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 69
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 69
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 69
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 69
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 68
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 67
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 66
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 65
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 65
Validation of the classification criteria for cryoglobulinaemic vasculitis 65
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 65
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. 64
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 64
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 64
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 63
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 61
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 61
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 61
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 61
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 60
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 59
New therapeutic effects of cilostazol in patients with ischemic disorders 59
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 59
Totale 10.970
Categoria #
all - tutte 52.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019449 0 0 0 0 0 0 0 0 62 100 187 100
2019/20202.732 397 202 182 254 242 380 239 131 123 144 253 185
2020/20211.919 129 189 261 165 230 89 167 38 239 106 255 51
2021/20221.961 219 158 60 102 131 75 69 296 92 141 272 346
2022/20233.741 461 485 283 597 262 434 163 334 428 53 131 110
2023/20241.438 101 630 76 94 67 243 125 94 8 0 0 0
Totale 15.621